What's Happening?
UnitedHealthcare (UHC) has announced it will remove prior authorization requirements for approximately 1,700 services starting October 1, following a pledge to reduce such requirements by 30% by the end of 2026. However, an analysis by the Center for Medicare
Advocacy suggests that these changes will have a minimal impact on Medicare Advantage (MA) enrollees. The bulk of the CPT codes being removed from prior authorization are concentrated in UHC’s commercial and individual plans. For Medicare Advantage and Dual Eligible Special Needs Plans (D-SNP), only about 70 CPT codes are listed for removal. Critics argue that many of the services no longer requiring prior authorization are 'low-stakes' or rarely used, meaning more expensive and critical services will remain subject to the same burdensome authorization processes. A KFF report indicated that MA plans denied between 12% and 18% of standard prior authorization requests in 2025, with UnitedHealth having the highest denial rate in MA at 17%.
Why It's Important?
The limited scope of UnitedHealthcare's prior authorization reductions for Medicare Advantage enrollees means that many beneficiaries will continue to face significant hurdles in accessing necessary medical care. Prior authorization is a major point of contention, often leading to delays or denials of coverage for essential services, particularly for expensive treatments and skilled nursing facility (SNF) care. This situation highlights ongoing concerns about the effectiveness of voluntary industry pledges to reduce administrative burdens and improve patient access. For MA enrollees, who are often vulnerable populations, continued restrictive prior authorization policies can lead to adverse health outcomes and increased financial stress. The disparity between the number of services removed from prior authorization in commercial plans versus MA plans also raises questions about the priorities of large insurers and the oversight of MA programs.
What's Next?
Despite UHC's announced changes, the Center for Medicare Advocacy and other consumer groups are calling for more substantial action from policymakers to address improper denials and delays in care within Medicare Advantage plans. This suggests that legislative or regulatory interventions may be sought to mandate more comprehensive reforms to prior authorization processes. Beneficiaries and healthcare providers will likely continue to advocate for greater transparency and accountability from MA plans regarding coverage decisions. The ongoing scrutiny of prior authorization practices across the health insurance industry indicates that this issue will remain a key focus for patient advocacy, regulatory bodies, and potentially future healthcare policy debates.
Beyond the Headlines
The debate over prior authorization extends beyond immediate patient access to care, touching upon the broader economics and ethics of managed care. While insurers argue that prior authorization helps control costs and prevent unnecessary procedures, critics contend it often serves as a barrier to care, leading to poorer health outcomes and increased administrative burdens for providers. This dynamic reflects a fundamental tension between cost containment and patient-centered care within the U.S. healthcare system. The limited impact of UHC's changes on Medicare Advantage enrollees also underscores the unique challenges faced by government-funded health programs, where the balance between private plan autonomy and public accountability is constantly negotiated. This situation could fuel further discussions about the role of private insurers in public health programs and the need for stronger consumer protections.
